Increased activity of matrix metalloproteinases in the cerebrospinal fluid of patients with HIV-associated neurological diseases

References

• Adamson D. C., Wildemann B., Sasaki M., Glass J. D., McArlhur J. C., Chistov V. I., Dawson T. M., Dawson V. L. Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41. Science 1996; 274: 1917–1921
   PubMed Web of Science ®Google Scholar
• Chaka W., Heydermann R., Gangaidzo I., Robertson V., Mason P., Verhoef J., Verhoeul A., Hoepelman A. I., University of Zimbabwe Meningitis Croup. Cytokine profiles in cerebrospinal fluid of human immunodeficiency virus-infected patients with cryptococcal meningitis, no leukocytosis despite high inter-leukin-8 levels. J Infect Dis 1997; 176: 1633–1636
   Google Scholar
• Cuzner M. L., Gveric D., Strand C., Loughlin A. J., Paemen L., Opdenakker G., Newcombe J. The expression of tissue-type plasminogen activator, matrix metallopro-teinase and endogenous inhibitors in the central nervous system in multiple sclerosis: comparison of stages in lesion evolution. J Neuropathol Exp Neurol 1996; 55: 1194–1204
   PubMed Web of Science ®Google Scholar
• Dhawan S., Toro L. A., Jones B. E., Meltzer M. S. Interaction between HIV-infected monocytes and the extracellular matrix: HIV-infected monocytes secrete neutral metalloproteases that degrade basement membrane protein matrices. J Leuk Biol 1992; 52: 244–248
   PubMedGoogle Scholar
• Dhawan S., Weeks B. S., Soderland C., Schnaper C., Toro L. A., Asthana S. P., Hewlett I. K., Stetler-Stevenson W. G., Yamada S. S., Yamada K. M., Meltzer M. S. HIV-1 infection alters monocyte interactions with human microvascular endothelial cells. J Immunol 1995; 154: 422–432
   PubMed Web of Science ®Google Scholar
• Eng R. H K, Bishburg E., Smith S. M. Cryptococcal disease in patients with acquired immunodeficiency syndrome. Am J Med 1986; 81: 19–23
   PubMed Web of Science ®Google Scholar
• Gendelman H. E., Ghorpade A., Persidsky Y. The neuropathogenesis of HIV-1 associated dementia. In Defense of the Brain: Current Concepts in the Immunopathogenesis and Clinical Aspects of CNS Infections, P. K. Peterson, J. S. Remington. Blackwell Science, USA 1997; 290–304
   Google Scholar
• Genis P., Jett M., Bernton E. W., Boyle T., Gelbard H. A., Dzenko K., Keane R. W., Resnick L., Mizrachi Y., Volsky D. J., Epstein L. G., Gendelman H. E. Cytokines and arachidonic acid metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease. J Exp Med 1992; 176: 1703–1718
   Google Scholar
• Gijbels K., Masure S., Carton H., Opdenakker G. Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders. J Neuroimnmnol 1992; 41: 29–34
   Web of Science ®Google Scholar
• Giraudon P., Buart S., Bernard A., Thomasset N., Belin M. L. Extracellular matrix-metalloproteinases and infection of the central nervous system with retrovirus human T-lymphotropic virus type I (HTLV.-I). Prog Neurobiol 1996; 49: 169–184
   Google Scholar
• Heussen C., Dowdle E. B. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal Biochem 1980; 102: 196–202
   PubMed Web of Science ®Google Scholar
• Kjeldsen L., Johnsen A. H., Sengelov H., Borregaard N. Isolation and primary structure of NGAL. a novel protein associated with human neutrophil gelatinase. J Biol Chem 1993; 268: 10425–10432
   PubMed Web of Science ®Google Scholar
• Lafrenie R. M., Wahl L. M., Esptein J. S., Hewlett I. K., Yamada K. M., Dhawan S. HIV.-Tat protein modulates the function of monocytes and alters their interactions with microvessel endothelial cells. A mechanism of HIV pathogenesis. J Immunol 1996; 156: 1638–1645
   PubMed Web of Science ®Google Scholar
• Liuzzi G. M., Mastroianni C. M., Fanelli M., Massetti A. P., Vullo V., Delia S., Riccio P. Myelin degrading activity in the CSF of HIV-1 infected patients with neurological disease. NeuroReport 1994; 6: 157–160
   Google Scholar
• Mastroianni C. M., Paoletti F., Valenti C., Vullo V., Delia S. Immune system activation and tumor necrosis factor-α release in AIDS-associated neurologic, damage. Immunol Infect Dis 1993; 3: 356–362
   Google Scholar
• Mastroianni C. M., Lichtner M., Mengoni F., Santopadre P., Vullo V., Delia S. Marked activation of the tumor necrosis factor system in AIDS-associated cryptococcosis. AIDS 1996; 10: 1436–1437
   Google Scholar
• Masiire S., Billiau A., Van Damme J., Opdenakker G. Human hepatoma cells produce an 85 kDa gelatinase regulated by phorbol 12-myristate 13-acetate. Biochim Biophys Acta 1990; 1054: 317–325
   Google Scholar
• Matrisian L. M. Metalloproteinases and their inhibitors in matrix remodelling. Trends Genet 1990; 6: 121–125
   PubMed Web of Science ®Google Scholar
• Nottet H. S L M, Persidsky Y., Sasseville V. G., Nukuma A. N., Bock P., Zhai Q. H., Sharer L. R., McComb R. D., Swindells S., Soderland C., Gendelman H. E. Mechanisms for transendothelial migration of HIV-1 -infected monocytes into brain. J Immunol 1996; 156: 1284–1295
   PubMed Web of Science ®Google Scholar
• Opdenakker G., Van Damme J. Cytokine-regulated proteases in autoimmune diseases. Immunol Today 1994; 15: 103–107
   PubMedGoogle Scholar
• Paemen L., Olsson T., Soderstrom M., Van Damme J., Opdenakker G. Evaluation of gelatinases and IL-6 in the cerebrospinal fluid of patients with optic neuritis, multiple sclerosis and other inflammatory neurological diseases. Eur J Neurol 1994; 1: 55–63
   Google Scholar
• Paul R., Lorenzl S., Koedel U., Sporer B., Vogel U., Frosch M., Pfister H. W. Matrix metalloproteinases contribute to the blood-brain barrier disruption during bacterial meningitis. Ann Neurol 1998; 44: 592–600
   PubMed Web of Science ®Google Scholar
• Petito C. K., Cash K. S. Blood-brain abnormalities in the acquired immunodeficiency syndrome: immunohislochemical localization of serum proteins in postmortem brain. Ann Neurol 1990; 32: 658–666
   Google Scholar
• Rosenberg G. A., Dencoff J. E., Correa N., Reiners M., Ford C. C. Effect of steroids on CSF matrix metalloproteases in multiple sclerosis: Relation to blood-brain barrier injury. Neurology 1996; 16: 1626–1632
   Google Scholar
• Sasseville V. G., Newman W., Brodie S. S., Hesterberg P., Pauley D., Ringler D. J. Monocyte adhesion to endothelium in simian immunodeficiency virus-induced AIDS encephalitis is mediated by vascular cell adhesion molecule-1/α4β1 integrin interaction. Am J Pathol 1994; 144: 27–40
   PubMedGoogle Scholar
• Simpson D. M., Tagliati M. Neurologic manifestations of HIV infection. Ann Intern Med 1994; 121: 769–785
   PubMed Web of Science ®Google Scholar
• Sporer B., Paul R., Koedel U., Grimm R., Wick M., Goebel P. D., Pfister H. W. Presence of matrix metallopro-teinase-9 activity in the cerebrospinal fluid of human immunodeficiency virus-infected patients. J Infect Dis 1998; 178: 954–857
   Google Scholar
• The Dana Consortium on Therapy. Clinical confirmation of the American Academy of Neurology algorithm for HIV-1 associated cognitive/motor disorder. Neurology 1996; 47: 1427–1454
   Google Scholar
• Vinters H. V., Kwok M. K., Ho H. W., Anders K. H., Tomiyasu U., Wolfson W. L., Robert F. Cytomegalovirus in the nervous system of patients with the acquired immunodeficiency syndrome. Brain 1989; 112: 245–268
   PubMed Web of Science ®Google Scholar
• Weeks B. S., Klotman M. E., Holloway E., Stetler-Stevenson W. G., Kleinman H. K., Klotman P. E. HIV-1 infection stimulates T cell invasiveness and synthesis of the 92-kDa type IV collagenase. AIDS Res Hum Retr 1993; 9: 513–518
   Google Scholar
• Weeks B. S. The role of HIV-1 activated leukocyte adhesion mechanisms and matrix metalloproteinases secretion in AIDS pathogenesis. Int J Mol Med 1998; 1: 361–366
   PubMed Web of Science ®Google Scholar
• Woessner F. The family of matrix metalloproteinases. Ann NY Acad Sci 1994; 732: 11–21
   PubMed Web of Science ®Google Scholar
• Yong V. W., Krekoski C. A., Forsyth P. A., Bell R., Edwards D. R. Matrix metalloproteinases and diseases of the CNS. TINS 1998; 21: 75–80
   PubMed Web of Science ®Google Scholar
• Zuger A., Louie A., Holzman R. S., Simberkoff M. S., Rahal J. J. Cryptococcal disease in patients with acquired immunodeficiency syndrome: diagnostic features and outcome of treatment. Ann Intern Med 1986; 104: 234–240
   PubMed Web of Science ®Google Scholar